More on Gadolinium adverse effects
"Europeans find more gadolinium-related adverse reactions
Problems with gadolinium-containing contrast agents administered to patients with renal impairment are more common than originally estimated. The lack of awareness among radiologists about the potential dangers for those at high risk is striking, according to researchers. In June 2006, the FDA advised against giving gadolinium-containing contrast agents during MRI exams to patients with renal impairment. The warning came after the Danish Medicines Agency reported that 25 patients with kidney failure developed a life-threatening condition known as nephrogenic systemic fibrosis (NSF, previously known as nephrogenic fibrosing dermopathy). "
Reference- Diagnostic Imaging Online
More on Gadolinium adverse effects
Reviewed by Sumer Sethi
on
Monday, November 13, 2006
Rating:
3 comments:
Good stuff. I just wanted to chim in and say that I really enjoy reading your blog. Keep up the good work!
Raul Wong,
Mobile Interim Solutions
I would like to see studies on the effects of gadolinium on patients with toxicant induced loss of tolerance disabilities. Many of these patients have suffered liver and kidney damage from toxic exposures and there is no information regarding a potential risk from their inability to detox the gadolinium.
As many people know, those who undergo MRI procedures often take gadolinium, a rare-earth metal that enhances MRI images. Since 1997, a growing number of patients with kidney disorders who have taken gadolinium have reported a serious, sometimes fatal condition called nephrogenic systemic fibrosis (NSF) or nephrogenic fibrosing dermopathy (NFD). People suffering from NSF/NFD experience a gradual tightening of the skin and connective tissue. NSF/NFD can lead to extreme pain, paralysis, and even death.
You can obtain a free legal consultation and or learn more about gadolinium and NSF at www.gadoliniumlawyers.net. The damaging and potentially fatal side effects of gadolinium mean that you deserve an in-depth legal review.
Post a Comment